SIX Structured Products | Bid | Ask | Notation | |
---|---|---|---|---|
Please note that data is only available after start of trading. |
Closing prev. day | 3.580 | ||||
Diff. absolute / % | -0.38 | -9.60% |
Last Price | - | Volume | - | |
Time | - | Date | - |
Details | Underlying | Payment profile | Risk Indicator | Information & Tools | Similar Products |
Name | Novo Nordisk AS (B) |
ISIN | CH1385094631 |
Valor | 138509463 |
Symbol | FNOAGV |
Type | Constant Leverage Certificate |
Type | Bull |
Ratio | 123.46 |
Factor | 8 |
SVSP Code | 2300 |
COSI Product | No |
Exercise type | American |
Currency | Swiss Franc |
First Trading Date | 11/11/2024 |
Settlement Type | Cash payout |
IRS 871m | Not applicable |
Currency safeguarded | No |
Pricing | Dirty |
Issuer | Bank Vontobel |
Average Spread | 0.34% |
Last Best Bid Price | 3.96 CHF |
Last Best Ask Price | 4.08 CHF |
Last Best Bid Volume | 3,200 |
Last Best Ask Volume | 3,200 |
Average Buy Volume | 20,480 |
Average Sell Volume | 20,480 |
Average Buy Value | 78,759 CHF |
Average Sell Value | 78,975 CHF |
Spreads Availability Ratio | 98.81% |
Quote Availability | 98.81% |